IBDEI1AT ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,23315,0)
 ;;=V45.4^^139^1433^34
 ;;^UTILITY(U,$J,358.3,23315,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23315,1,3,0)
 ;;=3^V45.4
 ;;^UTILITY(U,$J,358.3,23315,1,5,0)
 ;;=5^Arthrodesis Status
 ;;^UTILITY(U,$J,358.3,23315,2)
 ;;=^97131
 ;;^UTILITY(U,$J,358.3,23316,0)
 ;;=440.20^^139^1433^26
 ;;^UTILITY(U,$J,358.3,23316,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23316,1,3,0)
 ;;=3^440.20
 ;;^UTILITY(U,$J,358.3,23316,1,5,0)
 ;;=5^Arterisclerosis obliterans- extermity
 ;;^UTILITY(U,$J,358.3,23316,2)
 ;;=^294064
 ;;^UTILITY(U,$J,358.3,23317,0)
 ;;=701.8^^139^1433^35
 ;;^UTILITY(U,$J,358.3,23317,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23317,1,3,0)
 ;;=3^701.8
 ;;^UTILITY(U,$J,358.3,23317,1,5,0)
 ;;=5^Atrophy, fat pad
 ;;^UTILITY(U,$J,358.3,23317,2)
 ;;=^88076
 ;;^UTILITY(U,$J,358.3,23318,0)
 ;;=V54.89^^139^1433^15
 ;;^UTILITY(U,$J,358.3,23318,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23318,1,3,0)
 ;;=3^V54.89
 ;;^UTILITY(U,$J,358.3,23318,1,5,0)
 ;;=5^Aftercare,Post-op, Ortho
 ;;^UTILITY(U,$J,358.3,23318,2)
 ;;=Aftercare post Surg^328685
 ;;^UTILITY(U,$J,358.3,23319,0)
 ;;=V58.49^^139^1433^16
 ;;^UTILITY(U,$J,358.3,23319,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23319,1,3,0)
 ;;=3^V58.49
 ;;^UTILITY(U,$J,358.3,23319,1,5,0)
 ;;=5^Aftercare,following Surgery
 ;;^UTILITY(U,$J,358.3,23319,2)
 ;;=^295530
 ;;^UTILITY(U,$J,358.3,23320,0)
 ;;=274.00^^139^1433^27
 ;;^UTILITY(U,$J,358.3,23320,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23320,1,3,0)
 ;;=3^274.00
 ;;^UTILITY(U,$J,358.3,23320,1,5,0)
 ;;=5^Arthritis, Gouty NOS
 ;;^UTILITY(U,$J,358.3,23320,2)
 ;;=^338313
 ;;^UTILITY(U,$J,358.3,23321,0)
 ;;=736.76^^139^1433^11
 ;;^UTILITY(U,$J,358.3,23321,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23321,1,3,0)
 ;;=3^736.76
 ;;^UTILITY(U,$J,358.3,23321,1,5,0)
 ;;=5^Adductovarus (metatarsus) acquired
 ;;^UTILITY(U,$J,358.3,23321,2)
 ;;=^272748
 ;;^UTILITY(U,$J,358.3,23322,0)
 ;;=274.01^^139^1433^28
 ;;^UTILITY(U,$J,358.3,23322,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23322,1,3,0)
 ;;=3^274.01
 ;;^UTILITY(U,$J,358.3,23322,1,5,0)
 ;;=5^Arthritis, Gouty, Acute
 ;;^UTILITY(U,$J,358.3,23322,2)
 ;;=^338226
 ;;^UTILITY(U,$J,358.3,23323,0)
 ;;=V54.89^^139^1433^14
 ;;^UTILITY(U,$J,358.3,23323,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23323,1,3,0)
 ;;=3^V54.89
 ;;^UTILITY(U,$J,358.3,23323,1,5,0)
 ;;=5^Aftercare NEC
 ;;^UTILITY(U,$J,358.3,23323,2)
 ;;=^328685
 ;;^UTILITY(U,$J,358.3,23324,0)
 ;;=V67.09^^139^1433^13
 ;;^UTILITY(U,$J,358.3,23324,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23324,1,3,0)
 ;;=3^V67.09
 ;;^UTILITY(U,$J,358.3,23324,1,5,0)
 ;;=5^After Surgery F/U Visit
 ;;^UTILITY(U,$J,358.3,23324,2)
 ;;=^322080
 ;;^UTILITY(U,$J,358.3,23325,0)
 ;;=216.7^^139^1434^2
 ;;^UTILITY(U,$J,358.3,23325,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23325,1,3,0)
 ;;=3^216.7
 ;;^UTILITY(U,$J,358.3,23325,1,5,0)
 ;;=5^Benign neoplasm skin- lower limb, including hip
 ;;^UTILITY(U,$J,358.3,23325,2)
 ;;=^267636
 ;;^UTILITY(U,$J,358.3,23326,0)
 ;;=917.2^^139^1434^3
 ;;^UTILITY(U,$J,358.3,23326,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23326,1,3,0)
 ;;=3^917.2
 ;;^UTILITY(U,$J,358.3,23326,1,5,0)
 ;;=5^Blister- foot & toe(s) w/o mention of infection
 ;;^UTILITY(U,$J,358.3,23326,2)
 ;;=^275343
 ;;^UTILITY(U,$J,358.3,23327,0)
 ;;=917.3^^139^1434^4
 ;;^UTILITY(U,$J,358.3,23327,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23327,1,3,0)
 ;;=3^917.3
 ;;^UTILITY(U,$J,358.3,23327,1,5,0)
 ;;=5^Blister- foot & toe(s), infected
 ;;^UTILITY(U,$J,358.3,23327,2)
 ;;=^275344
 ;;^UTILITY(U,$J,358.3,23328,0)
 ;;=705.89^^139^1434^5
